三肽
血管平滑肌
细胞生物学
内皮干细胞
细胞外
内皮功能障碍
化学
血管内皮生长因子B
胞外囊泡
生物
生物化学
微泡
体外
癌症研究
小RNA
血管内皮生长因子A
肽
内分泌学
血管内皮生长因子
基因
平滑肌
血管内皮生长因子受体
作者
Tianyuan Song,Minzhi Zhou,Wen Li,Lin Zheng,Michael G. Gänzle,Mouming Zhao
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2022-10-18
卷期号:27 (20): 7025-7025
被引量:1
标识
DOI:10.3390/molecules27207025
摘要
Tripeptide LSW, initially identified as a potent ACE inhibitory peptide from soybean protein, was recently reported to exert a protective effect against angiotensin II-induced endothelial dysfunction via extracellular vesicles (EVs). However, the molecular mechanisms, especially in lipid accumulation-induced atherosclerosis, still remain unclear. The study aimed to investigate whether the protective effects of LSW against endothelial dysfunction on vascular endothelial cells (VECs) was via vascular smooth muscle cells (VSMCs)-derived miRNA-145 packaged in EVs. The miRNA-145 was concentrated in EVs from LSW-treated VSMCs (LEVs), internalized into the HVUECs, and targeted the programmed cell death protein 4 (PDCD4) expression of HUVECs. Oxidized low-density lipoprotein (oxLDL) was applied to induce endothelial dysfunction in HUVECs; oxLDL-induced endothelial dysfunction in HUVECs was attenuated by PDCD4 knockout or LEVs incubation. The results of this study suggested a novel function of LSW as a regulator on the functional EVs from vascular cells in the oxLDL-induced atherosclerotic model.
科研通智能强力驱动
Strongly Powered by AbleSci AI